Company Monitoring Page for Gilead-Sciences

Mizuho Reiterates “$88.00” Price Target for Gilead Sciences $GILD t.co/JHDCK4fKS4

Gilead Sciences, Inc. $GILD Expected to Announce Quarterly Sales of $5.27 Billion t.co/Iv64x62eF0 #stocks

Gilead Sciences $GILD Lowered to Sell at BidaskClub t.co/awRsrXFRH0

John C. Martin, PhD Former CEO, Gilead Sciences gives lifetime achievement award lecture #SDDS2019 t.co/iJ48NdIFKI

$GILD Gilead Sciences Inc. Option Order Flow Sentiment is 54.4% Bullish. t.co/sD9L6tOUzF

Bridges Investment Management Holding in Microsoft Com $MSFT Has Upped by $19.14 Million as Share Price Rose; Gilea… t.co/zmYnpHLACV

Gilead Sciences $GILD Given a $88.00 Price Target at Mizuho t.co/G68WfWyAHC

Gilead Sciences $GILD Given a $88.00 Price Target at Mizuho t.co/IUwVSIfF26

Mizuho Analysts Give Gilead Sciences $GILD a $88.00 Price Target t.co/mQQgHmq9nv #stocks

Spears Abacus Advisors Decreased By $359,352 Its Gilead Sciences $GILD Stake; uniQure N.V. $QURE Covered By 9 Bulli… t.co/z1x4NXyK8x

Now Hiring: Corporate Counsel at Gilead Sciences (Foster City, CA) t.co/LsosBIZhZE #corporatecounsel #lawyers #inhousecounsel

Gilead Sciences (GILD) Submits sNDA to FDA for Once-Daily Descovy® for HIV Pre-Exposure Prophylaxis ⁦… t.co/mZjdDBxPyA

#Bolsa Swing #Trading largos Gilead Sciences (GILD) en el Nasdaq. #Biotech

Fred Alger Management Trimmed Bluebird Bio $BLUE Stake by $2.09 Million; Valuation Rose; Gilead Sciences $GILD Hold… t.co/9D1FwSQMdB

Middleton & Co Has Lowered By $1.25 Million Its Roper Technologies $ROP Stake; Avalon Advisors Boosted Gilead Scien… t.co/LZjZS3X5Uv

Zacks Investment Management Cut Its Johnson & Johnson $JNJ Stake by $4.10 Million; Market Valuation Declined; Gilea… t.co/C166QyPlpi

JUST UPDATED: $GILD Gilead Sciences Valuation, Earnings Quality, and Dividend Safety Scores. Stock Analysis:… t.co/RZZcCw7LNP

“Gilead Sciences Inc said on Tuesday it will partner with privately held insitro to develop therapies for a… t.co/wOn51e7TPS

Atalanta Sosnoff Capital Lowered By $2.20 Million Its Gilead Sciences $GILD Stake; BERGENBIO AS ORDINARY SHARES NOR… t.co/9rWd6uir7x

Hepatitis C Drugs Market Revenue Opportunities Estimeted By Global Key Players Merck t.co/q0vkBbMpQ3 via @openPR

Health News: #Gilead teams up with #insitro for experimental #NASH treatments. #Reuters: t.co/YqEKKs586h

RT @NorbertElekes: Companies w/ highest profit per employee 10. Goldman Sachs 9. Taiwan Semiconductor 8. Alphabet 7. Apple 6. Amgen 5. Nat…

Gilead Sciences, Inc. $GILD Expected to Post Earnings of $1.60 Per Share t.co/IAlUGnujgs #stocks